Nightingale Research is one of Australia’s largest private clinical research organisations. With collectively over 35 years of clinical trials experience, we are at the cutting edge of cardiovascular research.
Nightingale Research is one of Australia’s largest private clinical research organisations. With collectively over 35 years of clinical trials experience, we are at the cutting edge of cardiovascular research.
Our clinical trials coordinators are the most experienced in Australia.
Clinical trials offer patients the opportunity to participate in new therapies with so potentially improving the health of the community.
For more information please contact us.
Tirzepatide V placebo Adults living with Obesity and established CV disease or very high risk of CV disease (without diabetes) with BMI ≥ 27
(recruitment due to commence in October)
Contact us to registerUpdated 23/08/22
Ziltivekimab (anti-inflammatory monoclonal antibody) versus placebo in patients with CVD, renal impairment and raised hs-CRP. (CV outcome study) monthly injection
Contact us to registerUpdated 23/08/22
Assess prevalence of raise lipoprotein(a), a new marker for CVD, in patients with CVD (MI or stent). Once-off blood test
Contact us to registerUpdated 23/08/22
Dulaglutide vs Tirzepatide – GLP1 inhibitors in diabetes with high cardiovascular risk – recruitment complete
Repatha vs placebo – PCSK9 inhibition in high risk cardiovascular patients with high cholesterols – recruitment complete
All Cardiologists in Hutt st, Goolwa and Windsor Gardens are independent and have chosen to use Nightingale’s state of the art services to run their practices
© Nightingale Cardiology 2020
Health Link: nighting